跳至主要内容
临床试验/JPRN-jRCT1030210391
JPRN-jRCT1030210391招募中1 期

A study on the safety of a low-protein diet for patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)

agayama Manabu0 个研究点目标入组 10 人开始时间: 2021年10月27日最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 65age old(—)
性别
All

入选标准

  • Fulfill three criteria below,
  • 1. Patients with liver damage (ALT 40 U/L or higher) due to nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
  • 2. BMI 25 or higher
  • 3. CAP value 248 db/m or higher at the first FibroScan

排除标准

  • Sarcopenia (AWGS2019)
  • Liver cirrhosis, alcoholic liver damage, autoimmune hepatitis, primary cholangitis, viral hepatitis, Wilson disease, and other liver diseases
  • Severe heart failure, diabetes mellitus, hypertension, interstitial pneumonitis, renal failure, autoimmune diseases, and infections
  • Insulin or steroids use, under hemodialysis
  • Malignant diseases
  • Under other dietary intervention

研究者

发起方
agayama Manabu

相似试验